Researchers find possible link between jumping genes and cancerous tumor growth

by Bob Yirka report

(Medical Xpress) -- Researchers based out of Harvard and Brigham Young Women’s Hospital have found compelling evidence that suggests “retrotransposon movement in somatic cells” - DNA sequences that jump (make copies of themselves that make their way to other sequences) might be responsible for the growth of some types of cancerous tumors.

The team, as they describe in their paper published in the journal Science, found examples of such in samples taken from several different kinds of in multiple patients.

Jumping genes have been seen in a wide variety of plants and animals but have been thought to be rare in mammals, which of course includes humans. Such jumps are thought to play a role in the evolutionary process because their activity generally results in mutations and thus changes in the plant or animal in which it occurs. The researchers note that the elements necessary for jumping genes are widely known to exist in mammals, including humans, but it was thought that their ability to jump was hampered by physiology.

In this new study, the team looked at five specific kinds of cancer: ovarian, multiple myeloma (a type of white blood cell cancer), colorectal, prostate, and those of the brain. Using a computer software computational method called Tea, for Transposable Element Analysis, they found that the incidence of jumping genes was higher than normal for all of the tumors studied except for those of the brain and blood, suggesting that jumping genes just might play a role in the development of several types of . As part of their findings, they noted that the jumping genes found in cancerous tumors tended to occur in the types of tumors that just happen to mutate in several types of cancers, which include some kinds of genes that are known to be tumor suppressors.

In their research, the team found that some transposable element (TE) insertions seemed to provide a path that led to an environment conducive to tumor growth and that different types of TEs were found in different types of tumors. Specifically, they found that out of 194 insertions, 183 were the so named L1 retrotransposons, 10 were of the Alu variety and just one was an ERV.

Validation testing has shown the Tea software used for testing to be ninety seven percent accurate, though the research team suspects the software likely misses some of the jumping genes due to repeats of the genes that occur in close proximity to one another.

More information: Landscape of Somatic Retrotransposition in Human Cancers, Science, DOI: 10.1126/science.1222077 . www.sciencemag.org/content/ear… 6/27/science.1222077

Related Stories

Jumping genes discovery 'challenges current assumptions'

Jun 12, 2009

Jumping genes do most of their jumping, not during the development of sperm and egg cells, but during the development of the embryo itself. The research, published this month in Genes and Development, "challenges standard assump ...

Researchers capture jumping genes

Feb 04, 2011

An ambitious hunt by Johns Hopkins scientists for actively "jumping genes" in humans has yielded compelling new evidence that the genome, anything but static, contains numerous pesky mobile elements that may help to explain ...

Mobile MITEs jump to fame in gene regulation

Jun 18, 2012

Moving genetic elements from one location to another in a genome makes for a very dynamic situation in terms of development and disease. An EU project has investigated a special type of micro transposable ...

Recommended for you

Endogenous hormones improve breast cancer risk models

13 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

14 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

nanotech_republika_pl
not rated yet Jun 30, 2012
I wonder if these changes in DNA were measured in typical somatic cells that form the niche for the stem cells or in the stem cells themselves.

Mutations in a stem cell would lead directly to cancerous cell being able to create a tumor around it. Mutations in other-than-stem cell would need to cause the cell to become a "stem" cell from which the whole tumor would form.